The Need for Innovation in Pharma

Best Prac*ces for the Use of Web 2.0 and Social Media Tools for Internal Collabora*on Erik van der Zijden BSc MBA Innova,on Manager

Erik van der Zijden Yara The Netherlands Floortje 1972 BSc Akzo Nobel Pharma 1995 MBA Area Management Intervet 1998 Export Sales Balkans Interna,onal Marke,ng Global Product Manager Equine An,parasi,cs Innova,on Manager Intervet/Schering‐Plough Enterprise 2.0 Mar,al Arts Podcas,ng Social Media Triumph SpiNire

1 Innova*on | why needed? 2 Social Media & Collabora*on | background 3 How we did it | Best prac,ces 4 Tips & Tricks

Conclusion

1 Innova*on | why?

Innova*on | why? 1 Less products in pipeline Less diversiﬁca,on in products Patent expiry Generic pressure Global branding versus local adapta,on Low on trust Pa,ents more informed Pricing pressure More regulatory involvement

Innova*on | why? 1 “ It’s a plug and play world. Because you can now innovate without having to emigrate, more and more world‐class innova,on is “ now star,ng from India Thomas L. Friedman ‐ The World is Flat

Innova*on | why? 1 The growth of intangibles Market value in trillions USD Human capital 7,5 Know‐how Trademarks Goodwill Collabora,on ac,vi,es .... 4,7 0,8 1,4 Intangible Capital 1985 Financial Capital 2005 Analysis of the biggest 150 companies in the world from 1985 All 2005

Innova*on | why? 1 “ Pharma will not only make white powders; it will sell a variety of products and therapeu,c healthcare packages, as well as a wide range of services to support pa,ents “ Pharma 2010: The Threshold of InnovaAon ‐ IBM Future Series

Innova*on | why? 1 Staatscourant 18th August 2008 Dutch Ministry of Health R&D‐spending in 3 industry sectors (€ 8 bln turnover) Biotechnology PharmaceuAcal industry Medical technology

Innova*on | why? 1 Staatscourant 18th August 2008 Main outcomes RelaAve high R&D‐investments (€ 1 bln or 12,5% of sales) Return on each € invested in R&D: € 1,1 (industry avg. € 3,0) InnovaAon is not managed correctly

Innova*on | why? 1 Staatscourant 18th August 2008 Recommenda*ons Reduce top‐down approach in InnovaAon Management Boost creaAvity and enthusiasm within the workforce Strengthen 3rd‐party collaboraAon, also across the border

n Innova*on | why? 1 ov te

Innova*on | why? 1 So, what is innova*on anyway?

Innova*on | why? 1 ‐e in•no•vate | in vat| ‐ “ ‐ A new way of doing something. It may refer to incremental, radical, and revolu,onary changes in thinking, products, processes, or “ organiza,ons. *on crea lue Va wikipedia.org

h Innova*on | why? 1 n e

Innova*on | why? 1 “ People are very open‐minded about new things ‐ as long as they’re exactly like the old ones. “ Charles KeWering

Innova*on | why? 1 Locked innova*on process Too busy with today’s things Market research, but no customer insights Customers involved too late or never Trapped by old company successes Risk averse Try new ini,a,ves only once Urgency only when pain (compe,,on, decreasing turnover) Internal research

1 Innova*on | why needed? 2 Social Media & Collabora*on | background

The Need for Innovation in Pharma

by René van den Bos

Accessibility

Categories

Upload Details

Usage Rights

1 Embed 12

Statistics

The Need for Innovation in Pharma Webinar Transcript